肝移植术后移植物抗宿主病6例临床分析
Clinical Analysis of 6 Cases of Graft-versus-Host Disease after Liver Transplantation
DOI: 10.12677/acm.2025.151086, PDF,   
作者: 宋笑林*, 许青冬:青岛大学青岛医学院,山东 青岛;蔡金贞#:青岛大学附属医院器官移植中心,山东 青岛
关键词: 肝脏移植移植物抗宿主病诊疗策略外周血嵌合体检测Liver Transplantation Graft-versus-Host Disease Diagnosis and Treatment Strategy Peripheral Blood Chimerism
摘要: 目的:总结单中心肝移植术后移植物抗宿主病(graft-versus-host disease, GVHD)的临床经验,探讨肝移植术后GVHD发生的临床表现、诊断方法及诊疗策略。方法:回顾性收集2013年7月至2024年1月于青岛大学附属医院进行各类肝移植手术后发生GVHD患者的临床资料,包括首发症状、实验室检查、发病时间等,描述性分析肝移植术后GVHD患者的临床特点及诊疗策略。结果:通过收集1263例各类肝移植手术患者临床资料,共确诊GVHD患者6例,发生率为0.47%;其中5例患者死亡,均死于严重感染导致的多器官功能衰竭,1例经治疗后存活至今。首发症状以皮疹、腹泻、发热为主;死亡患者实验室检查示三系减少伴严重骨髓抑制。组织病理学示皮肤基底层空泡变性、淋巴细胞浸润及坏死的嗜酸性角质形成。外周血嵌合体检测示供者来源T (CD8)细胞比例大于1%;呈受者与供者混合大嵌合状态。治疗方法主要有激素冲击、降低或停用免疫抑制剂、应用高级抗生素预防感染、个体化治疗及对症治疗。结论:肝移植术后GVHD死亡率高、预后差,现阶段诊断主要依靠典型临床表现及实验室检查,治疗以激素冲击为主要手段构成的综合治疗方法。
Abstract: Objective: The present study aims to comprehensively summarize the clinical experience regarding graft-versus-host disease (GVHD) subsequent to liver transplantation within a single medical center, and to meticulously explore the clinical manifestations, diagnostic approaches, and diagnosis and treatment strategy of GVHD in the post-liver transplantation setting. Methods: Clinical data of patients who manifested GVHD after assorted liver transplantation operations in the Affiliated Hospital of Qingdao University spanning from July 2013 to January 2024 were retrospectively collated. This encompassed initial symptomatology, laboratory evaluations, onset temporalities, and other relevant aspects. A descriptive analysis was then conducted to elucidate the clinical characteristics and diagnosis and treatment strategy of patients with post-liver transplantation GVHD. Results: Upon collecting the clinical data of 1263 patients who underwent diverse liver transplantation procedures, a total of six patients were definitively diagnosed with GVHD, yielding an incidence rate of 0.47%. Among these, five patients succumbed, all attributable to multiple organ failure consequent to severe infections. One patient has survived to date following treatment. The preponderant initial symptoms comprised dermatological eruptions, diarrhea, and febrile paroxysms. Laboratory examinations of the deceased patients exhibited pancytopenia accompanied by profound bone marrow suppression. Histopathological inspection unveiled vacuolar degeneration of the epidermal basal layer, lymphocyte infiltration, and necrotic eosinophilic keratinocytes. Peripheral blood chimerism assays demonstrated that the proportion of donor-derived T (CD8) cells surpassed 1%, signifying a large mixed chimeric state between the recipient and the donor. The cardinal treatment strategies incorporated steroid pulse therapy, reduction or cessation of immunosuppressive medications, application of advanced antibiotics for infection prevention, individualized treatment modalities, and symptomatic interventions. Conclusion: GVHD after liver transplantation has a high mortality rate and poor prognosis. At present, the diagnosis mainly relies on typical clinical manifestations and laboratory tests, and the treatment is a comprehensive treatment method mainly composed of steroid shock.
文章引用:宋笑林, 许青冬, 蔡金贞. 肝移植术后移植物抗宿主病6例临床分析[J]. 临床医学进展, 2025, 15(1): 634-641. https://doi.org/10.12677/acm.2025.151086

参考文献

[1] Wood, A., Eghtesad, B. and Lindenmeyer, C.C. (2020) Graft‐versus‐Host Disease after Liver Transplantation. Clinical Liver Disease, 15, 81-84. [Google Scholar] [CrossRef] [PubMed]
[2] Shen, C., Li, Y., Wang, B., Zong, Z., Lu, T., Maboyi, N., et al. (2022) HTLV-1 Infection of Donor-Derived T Cells Might Promote Acute Graft-versus-Host Disease Following Liver Transplantation. Nature Communications, 13, Article No. 7368. [Google Scholar] [CrossRef] [PubMed]
[3] Kneifel, F., Vogel, T., Bormann, E., Becker, F., Houben, P., Flammang, I., et al. (2023) Graft-versus-Host Disease Following Liver Transplantation: A Systematic Review of Literature. Hepatology Communications, 7, e0260. [Google Scholar] [CrossRef] [PubMed]
[4] Kim, G.Y., Schmelkin, L.A., Davis, M.D., El‐Azhary, R.A., Wieland, C.N., Leise, M.D., et al. (2018) Clinical and Histopathologic Manifestations of Solid Organ Transplantation‐Associated Graft‐versus‐Host Disease Involving the Skin: A Single‐Center Retrospective Study. Journal of Cutaneous Pathology, 45, 817-823. [Google Scholar] [CrossRef] [PubMed]
[5] Taylor, A.L., Gibbs, P., Sudhindran, S., Key, T., Goodman, R.S., Morgan, C.H., et al. (2004) Monitoring Systemic Donor Lymphocyte Macrochimerism to Aid the Diagnosis of Graft-versus-Host Disease after Liver Transplantation. Transplantation, 77, 441-445. [Google Scholar] [CrossRef] [PubMed]
[6] Cooper, J.P. and Abkowitz, J.L. (2023) How I Diagnose and Treat Acute Graft-versus-Host Disease after Solid Organ Transplantation. Blood, 141, 1136-1146. [Google Scholar] [CrossRef] [PubMed]
[7] Murali, A.R., Chandra, S., Stewart, Z., Blazar, B.R., Farooq, U., Ince, M.N., et al. (2016) Graft versus Host Disease after Liver Transplantation in Adults: A Case Series, Review of Literature, and an Approach to Management. Transplantation, 100, 2661-2670. [Google Scholar] [CrossRef] [PubMed]
[8] Cooper, J.P., Perkins, J.D., Warner, P.R., Shingina, A., Biggins, S.W., Abkowitz, J.L., et al. (2021) Acute Graft‐versus‐Host Disease after Orthotopic Liver Transplantation: Predicting This Rare Complication Using Machine Learning. Liver Transplantation, 28, 407-421. [Google Scholar] [CrossRef] [PubMed]
[9] Chinnakotla, S., Smith, D.M., Domiati-Saad, R., Agura, E.D., Watkins, D.L., Netto, G., et al. (2006) Acute Graft-versus-Host Disease after Liver Transplantation: Role of Withdrawal of Immunosuppression in Therapeutic Management. Liver Transplantation, 13, 157-161. [Google Scholar] [CrossRef] [PubMed]
[10] Lehner, F., Becker, T., Sybrecht, L., L??ck, R., Schwinzer, R., Slateva, K., et al. (2002) Successful Outcome of Acute Graft-versus-Host Disease in a Liver Allograft Recipient by Withdrawal of Immunosuppression. Transplantation, 73, 307-310. [Google Scholar] [CrossRef] [PubMed]
[11] Wang, B., Lu, Y., Yu, L., Liu, C., Wu, Z. and Liu, X. (2007) Diagnosis and Treatment for Graft-versus-Host Disease after Liver Transplantation: Two Case Reports. Transplantation Proceedings, 39, 1696-1698. [Google Scholar] [CrossRef] [PubMed]
[12] 朱晓璐, 郑树森. 肝移植术后移植物抗宿主病的诊治进展[J]. 中华移植杂志(电子版), 2019, 13(1): 75-80.
[13] Gonultas, F., Akbulut, S., Barut, B., Kutluturk, K. and Yilmaz, S. (2020) Graft-versus-Host Disease after Living Donor Liver Transplantation: An Unpredictable Troublesome Complication for Liver Transplant Centers. European Journal of Gastroenterology & Hepatology, 32, 95-100. [Google Scholar] [CrossRef] [PubMed]
[14] Hudspeth, M., Turner, A., Miller, N. and Lazarchick, J. (2014) Pancytopenia after Allogeneic Bone Marrow Transplant Due to Copper Deficiency. Journal of Pediatric Hematology/Oncology, 36, 316-318. [Google Scholar] [CrossRef] [PubMed]
[15] Hung, Y., Chang, Y., Wang, H., Lee, W., Lee, C. and Chen, C. (2022) Diagnostic and Therapeutic Dilemma in Stevens-Johnson Syndrome-Like Acute Graft-versus-Host Disease after Liver Transplantation: A Case Report. Frontiers in Immunology, 13, Article ID: 917782. [Google Scholar] [CrossRef] [PubMed]
[16] Chesdachai, S., Udompap, P., Yetmar, Z.A., Watt, K.D., Aqel, B.A., Yang, L., et al. (2022) Infectious Complications in Acute Graft‐versus‐Host Disease after Liver Transplantation. Transplant Infectious Disease, 24, e13843. [Google Scholar] [CrossRef] [PubMed]
[17] Ganoza, A., Mazariegos, G.V. and Khanna, A. (2019) Current Status of Graft-versus-Host Disease after Intestinal Transplantation. Current Opinion in Organ Transplantation, 24, 199-206. [Google Scholar] [CrossRef] [PubMed]
[18] Sudhindran, S., Taylor, A., Delriviere, L., Collins, V.P., Liu, L., Taylor, C.J., et al. (2003) Treatment of Graft-versus-Host Disease after Liver Transplantation with Basiliximab Followed by Bowel Resection. American Journal of Transplantation, 3, 1024-1029. [Google Scholar] [CrossRef] [PubMed]
[19] Rai, V., Dietz, N.E. and Agrawal, D.K. (2016) Immunological Basis for Treatment of Graft versus Host Disease after Liver Transplant. Expert Review of Clinical Immunology, 12, 583-593. [Google Scholar] [CrossRef] [PubMed]
[20] Ali, R., Ramdial, J., Algaze, S. and Beitinjaneh, A. (2017) The Role of Anti-Thymocyte Globulin or Alemtuzumab-Based Serotherapy in the Prophylaxis and Management of Graft-versus-Host Disease. Biomedicines, 5, Article No. 67. [Google Scholar] [CrossRef] [PubMed]
[21] Meng, X., Chen, X., Sahebally, Z., Xu, Y., Yin, S., Wu, L., et al. (2017) Cytokines Are Early Diagnostic Biomarkers of Graft-versus-Host Disease in Liver Recipients. Hepatobiliary & Pancreatic Diseases International, 16, 45-51. [Google Scholar] [CrossRef] [PubMed]
[22] Lewis, D., Glehn-Ponsirenas, R., Gulbahce, N., Hooey, L.J., Chaffin, J.M., Miles, J., et al. (2022) High Levels of Donor-Derived Cell-Free DNA in a Case of Graft-versus-Host-Disease Following Liver Transplantation. American Journal of Transplantation, 22, 973-976. [Google Scholar] [CrossRef] [PubMed]
[23] Doney, K.C., Mielcarek, M., Stewart, F.M. and Appelbaum, F.R. (2015) Hematopoietic Cell Transplantation after Solid Organ Transplantation. Biology of Blood and Marrow Transplantation, 21, 2123-2128. [Google Scholar] [CrossRef] [PubMed]
[24] 汪国营, 唐晖, 易慧敏, 等. 间充质干细胞治疗肝移植术后难治性急性移植物抗宿主病临床研究[J]. 中华移植杂志(电子版), 2015, 9(3): 133-136.